The venture is a pre-seed AI/biotech startup, and the EU Startup Grants provide funding for collaborative defence R&D, including dedicated EUDIS non-thematic SME calls, which could be a good fit. The programme allocates about €1B, which is a significant amount that could support the venture's growth. However, the programme's focus on defence R&D might not be a perfect match for the venture's focus on drug discovery and resistance mutations.